The impact of baseline body mass index on clinical outcomes in metastatic breast cancer: a prospective study.

BMC Res Notes · 2017 · PMC5667491 · PMID 29096707

Europe PMC DOI

hedged sentences

0.0780

closest p · 1.6× alpha

0.0780

boldest claim

The sentences

did not reach statistical significanceP = 0.078so close (0.05 < p ≤ 0.1)

When high BMI category was dissected into obese and overweight groups, only overweight patients demonstrated statistically significant longer median survival (19 months) than normal BMI patients ( P = 0.033), whereas the relatively better survival outcomes (16 months) in obese patients did not reach statistical significance ( P = 0.078) (Fig. 1 b).

also in 111,027 other papers

showed a trendno p-value reported

showed a trend toward improved PFS and OS in overweight patients when compared with normal weight and obese patients, and therefore suggested that being overweight should not be regarded as an adverse prognostic factor in patients with MBC [ 10 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.